MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NKE
9. USO
10. NVDA

Go back to MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies
(AMEX: MKKGY) Delayed: 33.29 -0.26 (0.77%)
Previous Close $33.55    52 Week High $ 
Open $32.68    52 Week Low $ 
Day High $33.48    P/E N/A 
Day Low $32.68    EPS $ 
Volume 168,623       

Merck & Co. (NYSE: MRK) Delayed: 128.66 +3.21 (2.56%)
Previous Close $125.45    52 Week High $65.46 
Open $125.83    52 Week Low $47.97 
Day High $128.78    P/E 87.52 
Day Low $125.83    EPS $1.47 
Volume 18,891,511